196 related articles for article (PubMed ID: 8554041)
1. Postoperative radiotherapy of medulloblastoma. Impact of radiation quality on treatment outcome.
Grabenbauer GG; Beck JD; Erhardt J; Seegenschmiedt MH; Seyer H; Thierauf P; Sauer R
Am J Clin Oncol; 1996 Feb; 19(1):73-7. PubMed ID: 8554041
[TBL] [Abstract][Full Text] [Related]
2. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
3. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma: time-dose relationship based on a 30-year review.
del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
[TBL] [Abstract][Full Text] [Related]
5. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
[TBL] [Abstract][Full Text] [Related]
6. The change in patterns of relapse in medulloblastoma.
Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
[TBL] [Abstract][Full Text] [Related]
7. Protracted radiotherapy treatment duration in medulloblastoma.
Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
[TBL] [Abstract][Full Text] [Related]
8. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
9. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ;
J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884
[TBL] [Abstract][Full Text] [Related]
10. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of conformal radiation therapy for medulloblastoma.
Merchant TE; Happersett L; Finlay JL; Leibel SA
Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
[TBL] [Abstract][Full Text] [Related]
12. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.
Kiltie AE; Lashford LS; Gattamaneni HR
Med Pediatr Oncol; 1997 May; 28(5):348-54. PubMed ID: 9121399
[TBL] [Abstract][Full Text] [Related]
13. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
14. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
15. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
[TBL] [Abstract][Full Text] [Related]
16. Treatment results for 149 medulloblastoma patients from one institution.
Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
[TBL] [Abstract][Full Text] [Related]
18. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
[TBL] [Abstract][Full Text] [Related]
19. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
